These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26926233)

  • 41. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy.
    Palumbo D; Spencer T; Lynch J; Co-Chien H; Faraone SV
    J Child Adolesc Psychopharmacol; 2004; 14(2):185-94. PubMed ID: 15319016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylphenidate-related growth impairment.
    Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
    J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
    Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.
    Günther T; Kahraman-Lanzerath B; Knospe EL; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):131-8. PubMed ID: 22364402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
    Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L;
    Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2015 Feb; 25():80-3. PubMed ID: 25645642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
    Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G
    Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
    Wilens T; Pelham W; Stein M; Conners CK; Abikoff H; Atkins M; August G; Greenhill L; McBurnett K; Palumbo D; Swanson J; Wolraich M
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):424-33. PubMed ID: 12649629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC; Schoemaker MM
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
    Işeri E; Kiliç BG; Senol S; Karabacak NI
    Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C; Paul I; Bauer S; Kivelitz H
    BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.
    Keulers EH; Hendriksen JG; Feron FJ; Wassenberg R; Wuisman-Frerker MG; Jolles J; Vles JS
    Eur J Paediatr Neurol; 2007 Jan; 11(1):21-8. PubMed ID: 17169593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder.
    Donnelly M; Haby MM; Carter R; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):592-601. PubMed ID: 15298581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T
    Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylphenidate to treat ADHD is not contraindicated in children with tics.
    Kurlan R
    Mov Disord; 2002 Jan; 17(1):5-6. PubMed ID: 11835432
    [No Abstract]   [Full Text] [Related]  

  • 59. Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder.
    Preiskorn J; Studer S; Rauh R; Lukačin R; Geffert C; Fleischhaker C; Clement HW; Schulz E; Biscaldi M
    Ther Drug Monit; 2018 Aug; 40(4):435-442. PubMed ID: 29750737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lower risk of stress fractures in young adults with ADHD under chronic treatment with methylphenidate.
    Schermann H; Ankory R; Shlaifer A; Dolkart O; Rotman D; Yoffe V; Karakis I; Chechik O
    Bone; 2019 Mar; 120():20-24. PubMed ID: 30267775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.